The treatment of medical cannabis through smoking does not allow patients who spend a significant part of their time in clinics, repeated hospitalizations, and rehabilitation to maintain continuity of pain reduction treatment. Research Podcast #2 describes a questionnaire study conducted at Rambam Health Care Campus in Haifa, Israel, among hospitalized patients with a cannabis license who could not consume their regular treatment during their hospitalization and, therefore, were prescribed the SyqeAir Inhaler, which can be used in hospitals.
Read the full article here and listen to this short podcast on the study (16 minutes):
